20581000087109: Canada French language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\French [International Organization for Standardization 639-1 code fr] language reference set (foundation metadata concept)\Canada French language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 10-Aug 2009. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

66851000087113 Canada French language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

66861000087111 Canada French language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Canada French language reference set (foundation metadata concept)	est un(e) (attribut)	French [International Organization for Standardization 639-1 code fr] language reference set	false	Inferred relationship	Some
Canada French language reference set (foundation metadata concept)	est un(e) (attribut)	French [International Organization for Standardization 639-1 code fr] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
CMT1F - Charcot-Marie-Tooth disease type 1F	Acceptable (foundation metadata concept)
CMT1X - Charcot-Marie-Tooth disease type 1, X-linked	Acceptable (foundation metadata concept)
CMT2A1 - Charcot-Marie-Tooth disease type 2A1	Acceptable (foundation metadata concept)
CMT2A2 - Charcot-Marie-Tooth disease type 2A2	Acceptable (foundation metadata concept)
CMT2B - Charcot-Marie-Tooth disease type 2B	Acceptable (foundation metadata concept)
CMT2C - Charcot-Marie-Tooth disease type 2C	Acceptable (foundation metadata concept)
CMT2D - Charcot-Marie-Tooth disease type 2D	Acceptable (foundation metadata concept)
CMT2E - Charcot-Marie-Tooth disease type 2E	Acceptable (foundation metadata concept)
CMT2F - Charcot-Marie-Tooth disease type 2F	Acceptable (foundation metadata concept)
CMT2G - Charcot-Marie-Tooth disease type 2G	Acceptable (foundation metadata concept)
CMT2I - Charcot-Marie-Tooth disease type 2I	Acceptable (foundation metadata concept)
CMT2J - Charcot-Marie-Tooth disease type 2J	Acceptable (foundation metadata concept)
CMT2K - Charcot-Marie-Tooth disease type 2K	Acceptable (foundation metadata concept)
CMT2L - Charcot-Marie-Tooth disease type 2L	Acceptable (foundation metadata concept)
CMT2M - Charcot-Marie-Tooth disease type 2M	Acceptable (foundation metadata concept)
CMT2N - Charcot-Marie-Tooth disease type 2N	Acceptable (foundation metadata concept)
CMT2Q - Charcot-Marie-Tooth disease type 2Q	Acceptable (foundation metadata concept)
CMT2R - Charcot-Marie-Tooth disease type 2R	Acceptable (foundation metadata concept)
CMT2U - Charcot-Marie-Tooth disease type 2U	Acceptable (foundation metadata concept)
CMT3X - Charcot-Marie-Tooth disease type 3, X-linked	Acceptable (foundation metadata concept)
CMT4A - Charcot-Marie-Tooth disease type 4A	Acceptable (foundation metadata concept)
CMT4B1 - Charcot-Marie-Tooth disease type 4B1	Acceptable (foundation metadata concept)
CMT4B2 - Charcot-Marie-Tooth disease type 4B2	Acceptable (foundation metadata concept)
CMT4C - Charcot-Marie-Tooth disease type 4C	Acceptable (foundation metadata concept)
CMT4D - Charcot-Marie-Tooth disease type 4D	Acceptable (foundation metadata concept)
CMT4E - Charcot-Marie-Tooth disease type 4E	Acceptable (foundation metadata concept)
CMT4F - Charcot-Marie-Tooth disease type 4F	Acceptable (foundation metadata concept)
CMT4G - Charcot-Marie-Tooth disease type 4G	Acceptable (foundation metadata concept)
CMT4H - Charcot-Marie-Tooth disease type 4H	Acceptable (foundation metadata concept)
CMT4J - Charcot-Marie-Tooth disease type 4J	Acceptable (foundation metadata concept)
CMT4X - Charcot-Marie-Tooth disease type 4, X-linked	Acceptable (foundation metadata concept)
CMT5X - Charcot-Marie-Tooth disease type 5, X-linked	Acceptable (foundation metadata concept)
CMT6X - Charcot-Marie-Tooth disease type 6, X-linked	Acceptable (foundation metadata concept)
CMTDIA - Charcot-Marie-Tooth disease, dominant intermediate type A	Acceptable (foundation metadata concept)
CMTDIB - Charcot-Marie-Tooth disease type B	Acceptable (foundation metadata concept)
CMTDIC - Charcot-Marie-Tooth disease type C	Acceptable (foundation metadata concept)
CMTDID - Charcot-Marie-Tooth disease type D	Acceptable (foundation metadata concept)
CMTDIE - Charcot-Marie-Tooth disease type E	Acceptable (foundation metadata concept)
CMTDIF - Charcot-Marie-Tooth disease type F	Acceptable (foundation metadata concept)
CMTX2 - Charcot-Marie-Tooth disease type 2, X-linked	Acceptable (foundation metadata concept)
CMUSE - cryptogenic multifocal ulcerous stenosing enteritis	Acceptable (foundation metadata concept)
CMVIg Cytogam CSL	Preferred (foundation metadata concept)
CMVIg Cytogam STR	Preferred (foundation metadata concept)
CMVIg immunoglobuline anti-cytomégalovirus non spécifié	Preferred (foundation metadata concept)
CNM4 - centronuclear myopathy type 4	Acceptable (foundation metadata concept)
COMIRNATY messenger ribonucleic acid 10 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug)	Preferred (foundation metadata concept)
COMIRNATY messenger ribonucleic acid 3 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug)	Preferred (foundation metadata concept)
COMIRNATY messenger ribonucleic acid 30 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug)	Preferred (foundation metadata concept)
COMIRNATY vaccine messenger ribonucleic acid 30 micrograms per 0.3 milliliter tris-sucrose formulation suspension for injection BioNTech Manufacturing GmbH (real clinical drug)	Preferred (foundation metadata concept)
COMVAX 7.5 micrograms and 5 micrograms per 0.5 milliliter suspension for injection Merck & Co. Inc. (real clinical drug)	Preferred (foundation metadata concept)
CORS - cerebellooculorenal syndrome	Acceptable (foundation metadata concept)
COVAXIN COVID-19 whole inactivated virus vaccine (real medicinal product)	Preferred (foundation metadata concept)
COVID-19	Preferred (foundation metadata concept)
COVID-19 Abdala vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 COMIRNATY pédiatrique vaccin contre la COVID-19 10 mcg/0.2 ml ARNm PB	Preferred (foundation metadata concept)
COVID-19 COMIRNATY pédiatrique vaccin contre la COVID-19 3 mcg/0.2 ml ARNm PB	Preferred (foundation metadata concept)
COVID-19 COMIRNATY tris-saccharose vaccin contre la COVID-19 30 mcg/0.3 ml ARNm PB	Preferred (foundation metadata concept)
COVID-19 COMIRNATY vaccin contre la COVID-19 30 mcg/0.3 ml ARNm PB	Preferred (foundation metadata concept)
COVID-19 COVAXIN vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 COVIFENZ PPP MED	Preferred (foundation metadata concept)
COVID-19 COVISHIELD vaccin contre la COVID-19 VP	Preferred (foundation metadata concept)
COVID-19 COVIran Barekat vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 COVOVAX	Preferred (foundation metadata concept)
COVID-19 Convidecia vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 CoronaVac vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 CoviVac vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 CureVac vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 EpiVacCorona vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 JANSSEN vaccin contre la COVID-19 Jan	Preferred (foundation metadata concept)
COVID-19 KCONVAC vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 MEDICAGO vaccin PPV contre la COVID-19 MED	Acceptable (foundation metadata concept)
COVID-19 MVC-COV1901 vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 NUVAXOVID NOV	Preferred (foundation metadata concept)
COVID-19 QazCovid-in vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 SINOPHARM-BIBP vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 SINOPHARM-WIBP vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 SPIKEVAX vaccin bivalent (Original / Omicron BA.1) contre la COVID-19 0.10 mg/mL ARNm Mod	Preferred (foundation metadata concept)
COVID-19 SPIKEVAX vaccin bivalent (Original / Omicron BA.4/BA.5) contre la COVID-19 0.10 mg/mL ARNm Mod	Preferred (foundation metadata concept)
COVID-19 SPIKEVAX vaccin contre la COVID-19 0.10 mg/mL ARNm Mod	Preferred (foundation metadata concept)
COVID-19 SPIKEVAX vaccin contre la COVID-19 0.20 mg/mL ARNm Mod	Preferred (foundation metadata concept)
COVID-19 Soberana 02	Preferred (foundation metadata concept)
COVID-19 SpikoGen	Preferred (foundation metadata concept)
COVID-19 Sputnik Light vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 Sputnik V vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 VACCIN CONTRE LA COVID-19 DE PFIZER-BIONTECH ARNm PB	Acceptable (foundation metadata concept)
COVID-19 VACCIN D’ASTRAZENECA CONTRE LA COVID-19 AZC	Acceptable (foundation metadata concept)
COVID-19 VACCIN NOVAVAX CONTRE LA COVID-19 NOV	Acceptable (foundation metadata concept)
COVID-19 VAXZEVRIA vaccin contre la COVID-19 AZC	Preferred (foundation metadata concept)
COVID-19 ZIFIVAX vaccin contre la COVID-19	Preferred (foundation metadata concept)
COVID-19 aigüe	Preferred (foundation metadata concept)
COVID-19 non spécifié	Preferred (foundation metadata concept)
COVID-19 pédiatrique ARNm non spécifié	Preferred (foundation metadata concept)
COVID-19 soupçonnée	Preferred (foundation metadata concept)
COVID-19 vaccin codant la protéine de spicule recombinante non spécifié	Preferred (foundation metadata concept)
COVID-19 vaccin à l'acide ribonucléique messager non spécifié	Preferred (foundation metadata concept)
COVID-19 vaccin à particules pseudo-virales non spécifié	Preferred (foundation metadata concept)
COVID-19 vaccin à vecteur viral non réplicatif non spécifié	Preferred (foundation metadata concept)
COVID-19 vaccin à virus entier inactivé non spécifié	Preferred (foundation metadata concept)
COVIFENZ virus-like particle 3.75 micrograms per 0.5 milliliter emulsion for injection Medicago Inc. (real clinical drug)	Preferred (foundation metadata concept)
COVISHIELD non-replicant vector 0.5 milliliter solution for injection Verity Pharmaceuticals Inc. (real clinical drug)	Preferred (foundation metadata concept)
COVIran Barekat COVID-19 whole inactivated virus vaccine (real medicinal product)	Preferred (foundation metadata concept)

Start Previous Page 45 of 1757 Next End

Reference Sets

Canada English language reference set (foundation metadata concept)

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
66851000087113	Canada French language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
66861000087111	Canada French language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)